Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Hans, Ikenberg"'
Autor:
Linda A. Liang, Luana F. Tanaka, Kathrin Radde, Ulrike Bussas, Hans Ikenberg, Daniëlle A. M. Heideman, Chris J. L. M. Meijer, Maria Blettner, Stefanie J. Klug
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background A persisting high-risk human papillomavirus (HR-HPV) infection is causal for cervical cancer; however, there is limited population-based data on the prevalence of HPV infections in Germany. We assessed the age and type-specific HP
Externí odkaz:
https://doaj.org/article/1e105fc9b1a142a1889cb9c2ed5705ef
Autor:
Linda A. Liang, Sylke R. Zeissig, Gunther Schauberger, Sophie Merzweiler, Kathrin Radde, Sabine Fischbeck, Hans Ikenberg, Maria Blettner, Stefanie J. Klug
Publikováno v:
BMC Women's Health, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background A considerable proportion of cervical cancer diagnoses in high-income countries are due to lack of timely follow-up of an abnormal screening result. We estimated colposcopy non-attendance, examined the potential factors associated
Externí odkaz:
https://doaj.org/article/33679fc8290c47d1acf7c126d05a368b
Autor:
Martina Schmitz, Kristin Eichelkraut, Dana Schmidt, Ilona Zeiser, Ziad Hilal, Zena Tettenborn, Alfred Hansel, Hans Ikenberg
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background A change of cervical cancer screening algorithms to an HPV-based screening setting is discussed in many countries, due to higher sensitivity of HPV testing compared to cytology. Reliable triage methods are, however, an essential p
Externí odkaz:
https://doaj.org/article/5044227fd5e64e5d9bca6753f8794d90
Publikováno v:
Geburtshilfe und Frauenheilkunde. 82:1378-1386
Introduction On 1 January 2020 the screening programme for the prevention of cervical cancer in women from the age of 35 years of the Statutory Health Insurance (GKV) in Germany changed from an annual cytology examination to cytological and HPV co-te
Publikováno v:
Cancer Cytopathology.
Autor:
Gunther Schauberger, Dirk Schriefer, Hans Ikenberg, Charles James Kirkpatrick, Linda A. Liang, Katja Schwarzer, Heinz Kölbl, Thomas Einzmann, Maria Blettner, Kathrin Radde, Sylke Ruth Zeissig, Chris J.L.M. Meijer, Arno Franzen, Stefanie J. Klug
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 30:474-484
Background: Some countries have implemented stand-alone human papillomavirus (HPV) testing while others consider cotesting for cervical cancer screening. We compared both strategies within a population-based study. Methods: The MARZY cohort study was
Autor:
Hans Ikenberg, Julia Gallwas, Gerd Gross, Rafael T. Mikolajczyk, Martin Schlaeger, Ralf Köllges, Klaus Doubek, Klaus J. Neis, Jens Peter Klußmann, Sven Tiews, Hans-Jürgen Laws, Alexander Nast, Friederike Gieseking, Gabriela L. Avila Valle, Achim Schneider, Peter Hillemanns, Herbert Pfister, Peter Schneede, Matthew Gaskins, Ulrike Wieland, Andreas M. Kaufmann, Heidemarie Haase, Norbert H. Brockmeyer, Markus Bickel, Ricardo Niklas Werner, Karl Ulrich Petry, Markus Knuf, Johannes Jongen, Sigrun Smola, Magnus von Knebel Doeberitz
Publikováno v:
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 19:479-494
Autor:
Ralf Köllges, Gerd Gross, Martin Schlaeger, Jens Peter Klußmann, Sven Tiews, Hans-Jürgen Laws, Peter Hillemanns, Klaus J. Neis, Julia Gallwas, Peter Schneede, Klaus Doubek, Norbert H. Brockmeyer, Markus Bickel, Matthew Gaskins, Rafael T. Mikolajczyk, Karl Ulrich Petry, Ulrike Wieland, Gabriela L. Avila Valle, Heidemarie Haase, Markus Knuf, Johannes Jongen, Hans Ikenberg, Andreas M. Kaufmann, Herbert Pfister, Alexander Nast, Achim Schneider, Sigrun Smola, Magnus von Knebel Doeberitz, Friederike Gieseking, Ricardo Niklas Werner
Publikováno v:
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 19:479-494
Anogenital and oropharyngeal infections with human papilloma viruses (HPV) are common. Clinically manifest disease may significantly impact quality of life; the treatment of HPV-associated lesions is associated with a high rate of recurrence and inva
Autor:
Linda Liang, Thomas Einzmann, Sylke Ruth Zeissig, Stefanie J. Klug, Heinz Koelbl, Arno Franzen, Katja Schwarzer, Gunther Schauberger, Charles James Kirkpatrick, Dirk Schriefer, Chris J.L.M. Meijer, Kathrin Radde, Hans Ikenberg, Maria Blettner, Peter J.F. Snijders
Publikováno v:
International Journal of Epidemiology. 50
Background Cervical cancer screening can be conducted with cytology and Human Papillomavirus (HPV) testing but few studies have compared the latter directly to concomitant testing (co-testing). We compared these strategies to determine appropriate sc
Autor:
Stefanie J. Klug, Olaf Reich, Axel Schäfer, Matthias W. Beckmann, Thomas Iftner, Monika Nothacker, Klaus Friese, K. Ulrich Petry, Hans Ikenberg, Christoph Grimm, M.K. Fehr, Peter Hillemanns, M. Gebhardt, Juliane Hädicke, Uwe Siebert, Thomas Langer, Dietmar Schmidt, Willi Sauerbrei, Gaby Sroczynski, Andreas M. Kaufmann, U. Freitag, Marc Arbyn, Thomas Löning, M Jentschke, Lars Horn, Simone Wesselmann, Michael Friedrich, Michael Pawlita, Ulrike Seifert, Anja Mehnert, Christian Dannecker, Markus Follmann, K. Münstedt, Joachim Weis, Achim Schneider, Jos Kleijnen, Manfred Steiner
Publikováno v:
Geburtshilfe und Frauenheilkunde. 79:160-176
Aims Annual opportunistic screening for cervical carcinoma has been done in Germany since 1971. The creation of this S3 guideline meets an important need, outlined in the National Cancer Plan, with regard to screening for cervical cancer, as this gui